Delek US Holdings (DK) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts DK Hot Sheet
Price: $67.22 --0%
Financial Fact:
Total non-operating expenses: 264.2M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Total non-operating expenses: 264.2M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Delek US Holdings (NYSE: DK) reported Q4 EPS of $0.88, in-line with the analyst estimate of $0.88. Revenue for the quarter came in at $4.48 billion versus the consensus estimate of $3.43 billion.
For earnings history and earnings-related data on Delek US Holdings (DK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
- Telesat Corporation (TSAT) Misses Q2 EPS by 1006c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
